Language:
Finally, the Regulation for Research and Medicinal Use of Cannabis and its Pharmacological Derivatives is enacted
January 13, 2021
After a long wait, on January 12, 2020, the General Health Law Regulation on Sanitary Control for the Production, Research and Medicinal Use of Cannabis and its Pharmacological Derivatives was published in the Federal Official Gazette.
The new Cannabis Regulation is intended to regulate, promote, and monitor the use of cannabis and its derivatives for medicinal use. The regulation includes provisions regarding primary production, research, manufacturing of pharmacological derivatives and medicines, distribution, advertising, prescription, and commercialization.
This regulation will come into force on January 13, 2020.
OLIVARES is analysing in detail the effects of this regulation, to inform and advise our clients.
Newsletters - Life Science
- Civil Court in Mexico Acquits Holder of Pharmaceutical Patent Rights to Compensate Damages Claimed by Alleged Infringer. September 7, 2021
- Update: Mexico – Government Procurement by the United Nations Office for Project Services December 4, 2020
- Mexico could grant marketing authorizations for medicines of foreign origin in five days November 13, 2020
- Labeling of medicines exclusively intended for public sector in Mexico December 4, 2020
- Data Package Exclusivity (DPE). Mexico intends to pass a new law to fully recognize DPE rights in the domestic law. March 11, 2011
- Mexico: The Supreme Court of Justice authorized the industrial use of cannabis. December 8, 2021
- OLIVARES & CIA LITIGATION STRATEGY ENDS WITH MEXICAN SUPREME COURT DECISION SECURING PROTECTION FOR PHARMA PRODUCT PATENTS AND ESTABLISHING PRECEDENT FOR LINKAGE REGULATIONS January 13, 2010
- New prohibition of vapes and electronic cigarettes in Mexico. June 2, 2022